Quinolone treatment for pediatric bacterial meningitis: A comparative study of trovafloxacin and ceftriaxone with or without vancomycin

Pediatric Infectious Disease Journal

Volumn 21, Issue 1, 2002, Pages 14-22

  Sáez Llorens, Xavier ^a   McCoig, Cynthia ^a   Feris, Jesús M ^a   Vargas, Sergio L ^a   Klugman, Keith P ^a   Hussey, Gregory D ^a   Frenck, Robert W ^a   Falleiros Carvalho, Luisa H ^a   Arguedas, Adriano G ^a   Bradley, John ^a   Arrieta, Antonio C ^a   Wald, Ellen R ^a   Pancorbo, Salvador ^a   McCracken Jr , George H ^a   Azimi, Parvin ^a   Kelley, Robin ^a   LaVia, William V ^a   Meissner, Cody ^a   Noel, Gary ^a   Overturf, Gary D ^a   Rathore, Mobeen ^a   Castaño, Elizabeth ^a   Parra, Mercedes Macias ^a   Morayta, Alfredo ^a   Dos Santos, Boaneventura Antonio ^a   Maia, Tania Maria Rohde ^a   Pimentel, Analiria ^a   Chavez, Ana ^a   Gatica, Luis Eduardo ^a   Soza, Guillermo ^a   Tassara, Enzo ^a   Villaroel, Julita ^a   Wu, Elba ^a   Apra, Ernestina ^a   Tregnaghi, Miguel ^a   Venter, Andre ^a   Cooper, Peter A ^a   Cotton, Mark F ^a   Madhi, Shabir ^a   Karaszi, Julia ^a   more..

^a NONE

Author keywords

Bacterial meningitis; Children; Trovafloxacin

Indexed keywords

CEFTRIAXONE; DEXAMETHASONE; QUINOLONE DERIVATIVE; TROVAFLOXACIN; VANCOMYCIN;

ABDOMINAL PAIN; ANTIMICROBIAL ACTIVITY; ARTHRALGIA; ARTICLE; BACTERIAL MENINGITIS; CEREBROSPINAL FLUID ANALYSIS; CHILD; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DRUG EFFICACY; DRUG PENETRATION; DRUG SAFETY; FEMALE; HAEMOPHILUS INFLUENZAE TYPE B; HEPATITIS; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; MULTICENTER STUDY; NEISSERIA MENINGITIDIS; NUCLEAR MAGNETIC RESONANCE IMAGING; OUTCOMES RESEARCH; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; SEIZURE; STATISTICAL ANALYSIS; STREPTOCOCCUS PNEUMONIAE; THRUSH; TREATMENT OUTCOME;

EID: 0036141406     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200201000-00004     Document Type: Article

References (20)

1. The challenge of penicillin-resistant Streptococcus pneumoniae meningitis: Current antibiotic therapy in the 1990s
2. Ceftriaxone failure in meningitis caused by Streptococcus pneumoniae with reduced susceptibility to beta-lactam antibiotics
3. Treatment failure with use of a third-generation cephalosporin for penicillin-resistant pneumococcal meningitis: Case report and review
4. Cephalosporin treatment failure in penicillin- and cephalosporin-resistant Streptococcus pneumoniae meningitis
5. Therapeutic failure with high-dose cefotaxime in pneumococcal meningitis
6. Trovafloxacin, a new fluoroquinolone with potent activity against Streptococcus pneumoniae
7. Evaluation of trovafloxacin: A new fluoroquinolone for treatment of experimental penicillin- and cephalosporin-resistant pneumococcal meningitis
8. Quinolone antibiotics in the therapy of experimental pneumococcal meningitis in rabbits
9. CSF penetration of intravenous trovafloxacin in children
10. Pharmacokinetics of a fluoronaphthyridone, trovafloxacin, in infants and children following administration of a single intravenous dose of alatrofloxacin
11. General guidelines for the treatment of infections of the central nervous system: Evaluation of new anti-infective drugs for the treatment of acute bacterial meningitis
12. A prospective randomized comparison of cefepime and cefotaxime for the treatment of bacterial meningitis in infants and children
13. Randomized comparison of meropenem with cefotaxime for treatment of bacterial meningitis
14. A randomised comparison of meropenem with cefotaxime or ceftriaxone for the treatment of bacterial meningitis in adults
15. Prospective, randomised, investigator-blinded study of the efficacy and safety of meropenem vs. cefotaxime therapy in bacterial meningitis in children
16. Three-year multicenter surveillance of pneumococcal meningitis in children: Clinical characteristics and outcome related to penicillin susceptibility and dexamethasone use
17. Clinical outcomes of meningitis caused by Streptococcus pneumoniae in the era of antibiotic resistance
18. Delayed cerebrospinal fluid sterilization and adverse outcome of bacterial meningitis in infants and children
19. Specific toxicologic aspects of the quinolones
20. Ciprofloxacin in pediatrics: Worldwide clinical experience based on compassionate use: Safety report